Aarti Industries Signs $150 Million Supply Deal With Global Agrochemical Company

Aarti Industries Limited has entered into a multi-year supply agreement with a leading global agrochemical company for the supply of an important agrochemical intermediate used in crop protection products.
The contract will run until March 31, 2030, and is expected to generate around $150 million in revenue over the duration of the agreement. The deal also expands the company’s existing business relationship with the customer by increasing supply volumes.
Supply of Agrochemical Intermediate
Under the agreement, Aarti Industries will manufacture and supply a key intermediate used in crop protection formulations. These products are widely used in agriculture to protect crops and improve productivity.
The company will leverage its integrated manufacturing facilities, strong process chemistry expertise, and global regulatory compliance capabilities to meet the requirements of the contract.
Capacity Available Without Additional Investment
The company said it already has enough manufacturing capacity to fulfil the new contract. This means the agreement will increase production volumes and capacity utilisation without requiring additional capital expenditure (capex).
This helps the company improve operational efficiency while strengthening revenue visibility in the coming years.
Strengthening Position in Global Supply Chains
The partnership further strengthens Aarti Industries Limited’s position as a trusted supplier for global agrochemical innovators. It also increases the company’s role in long-term speciality chemical supply chains.
The deal highlights India’s growing importance as a global manufacturing hub for speciality chemicals, supporting global companies looking to diversify supply chains and reduce geopolitical risks.
Management Commentary
Commenting on the development, Suyog Kotecha, CEO of Aarti Industries Limited, said the agreement strengthens the company’s relationship with global agrochemical companies.
He added that Aarti’s strong process chemistry expertise, integrated manufacturing value chain, and ability to deliver reliable large-scale supply continue to make it a preferred partner for international customers.
About Aarti Industries
Aarti Industries Limited is a leading global speciality chemicals manufacturer known for its strong expertise in process chemistry and scale-up engineering.
The company holds top global market positions (1st–4th) in about 75% of its product portfolio and serves several major international and domestic customers.
Read More:Adani Enterprises Share Price in Focus; Incorporates Wholly Owned Subsidiary CORR Tollways Limited!
Aarti Industries Share Price Movement
Aarti Industries share price (NSE: AARTIIND) was trading at ₹438.40, up ₹8.25 or 1.92% in Thursday’s session as of 10:54 AM (March 12, 2026). The stock opened at ₹430 and moved between an intraday high of ₹440.25 and a low of ₹420.30. The company currently has a market capitalisation of about ₹15.88 thousand crore, with a price-to-earnings (P/E) ratio of 42.15.
Conclusion
The $150 million supply agreement marks another important milestone for Aarti Industries Limited. The deal strengthens its long-term revenue visibility, improves capacity utilisation, and reinforces its role as a key partner in the global agrochemical supply chain.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 12, 2026, 11:22 AM IST

Kusum Kumari
- RPG Life Sciences Share Price Crashes Over 10% After Q2 FY27 Results
- ACME Solar Share in Focus as Subsidiary Collaborates with NTPC on 400 MW Renewable Energy Project
- Hikal Share Price Gains Over 8%; Achieves Swissmedic GMP Certification for Bengaluru Facility
- Sun Pharma Share Price Gains Nearly 2%; Secures FDA Approval for ILUMYA in Treating Psoriatic Arthritis
- Best Long-Term Stocks in November 2026 Based on 5 Year CAGR: BSE, Adani Power and More




